Navigation Links
Differing attitudes found between women and doctors concerning menstrual suppression

PHILADELPHIA More than the two thirds of the women in a national survey say that they are interested in suppressing their menstrual periods but many of them arent sure if its safe. Yet when physicians are polled, 97 percent say that continuous oral contraceptive therapy to suppress menstruation is, in fact, medically safe and acceptable. The survey results were presented by Kurt Barnhart MD, MSCE from the University of Pennsylvania School of Medicine at the Association of Reproductive Health Professionals (ARHP) Reproductive Health 2007 conference.

The gap between physician and patient understanding concerning the necessity of monthly periods is obvious, said Dr. Barnhart, Associate Professor and Director of Clinical Research for the Department of Obstetrics & Gynecology. It is our hope that based on these findings physicians will begin to more readily initiate dialogue with their female patients about continuous therapy -- helping to eliminate the misconception that periods are a medical necessity and to emphasize the safety and viability of menstrual suppression.

Multiple oral contraceptives are already available to reduce menstruation and the FDA recently approved the first continuous oral contraceptive designed to suppress a womans menstrual cycle. And according to this study, women are increasingly interested in exercising their options. The study found that 63 percent of women reported being extremely or somewhat interested in not having a period. Symptoms cited as the most bothersome aspects of menstruation included cramping, mood swings, bloating and headaches/body aches, while associated personal frustrations cited included avoiding exercise and sexual intercourse, eating more and a decrease in work productivity.

Why would a physician recommend a woman suppress her menses?

The symptoms that often accompany menstruation from depression to bloating and headaches can significantly disrupt womens lives, said Dr. Barnhart. Menstruation is not medically necessary. Now that we have products that have proven to be safe and effective at suppressing menstruation, we can offer increasing options for women.

Indeed it seems a clearer patient-physician dialogue is required to eliminate confusion regarding menstrual suppression and continuous use oral contraceptives. Of the 12% of patients who indicated that they have discussed the idea of eliminating or reducing periods with their doctor; nearly half of those said that they were the ones to raise the issue, not their physicians. But their physicians tell a different story. By contrast, four out of 5 physicians reported discussing continuous use oral contraceptive use with their patients, and 77% reported that they raised the topic.

This disconnect may be related to simple semantics, according to Dr. Barnhart.

Weve found that physicians and their patients discuss this topic differently, with doctors using the medical term menstrual suppression, while their patients simply talk about not having a period, he said. Breaking down this language barrier by speaking in simpler, more patient-friendly terms could have a significant positive impact on understanding.

Oral contraceptives were initially designed with a week of inactive tablets taken every month to mimic the natural experience of menstruation. Continuous use oral contraceptives simply eliminate these inactive tablets, thereby eliminating withdrawal bleeding. A study published in the December, 2006 issue of Contraception demonstrated the safety and effectiveness of continuous-use oral contraceptives that can eliminate menstrual cycles. Researchers concluded that a continuous-use, low-dose regimen of oral contraceptives was safe and as effective as traditional oral contraceptives, and that the decrease in menstrual cycle symptoms during continuous use therapy represented an increase in quality of life.


Contact: Marc Kaplan
University of Pennsylvania School of Medicine

Related medicine news :

1. Differing reactions to anti clotting drugs may be due to genetic variation.
2. Differing Ideas on Management of Alzheimer’s diseas
3. Risk Attitudes And Consequences Of College Drinking
4. Attitudes About Aging Different from Reality
5. Sexual Attitudes Help Explain Narcissists’ Relationship Problem
6. Men and Women Change Attitudes to Sex When in an Intimate Relationship
7. High-risk Sexual Behavior Adolescents Attract Peers With Similar Attitudes
8. Distraction therapy found very effective in postoperative patients
9. Genetic differences found between Male and Female brains
10. Breastfeeding not found to have an impact on weight of the child.
11. Common Cold Found to Fight Cancer Cells
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: